CB Therapeutics

📍 Carlsbad, United States🗓 Founded 2015👥 15 employees💰 Last funded Aug 2018
Biotechnology🌐 cbthera.com
Website LinkedIn
CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems. CB Therapeutics’ expertise in synthetic genomics, bio-engineering and cellular production processes can produce a broad range of phytochemicals faster, more sustainably, at greater yields and with higher purity, consistency and efficiency than competitive platforms. CB Therapeutics is focused on the discovery, research, development and production of tryptamines, cannabinoids and other molecules and compounds to advance Neuroscience and bring therapeutics to market to solve mankind’s most challenging mental healthcare and social problems.
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2015
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2015–2018 · investors recorded per year
201512017120182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in CB Therapeutics?
CB Therapeutics has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did CB Therapeutics last raise funding?
The most recent investment in CB Therapeutics recorded on gritt.io was in August 2018.
When was CB Therapeutics founded?
CB Therapeutics was founded in 2015.
What industry is CB Therapeutics in?
CB Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is CB Therapeutics based?
CB Therapeutics is headquartered in Carlsbad, United States.